Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the Master Agreement

IMO, it doesn't really matter. PDS is jointly owned by TPL and PTSC. Their books are open, and accounting principles must be adhered to. PDS is just a money funnel and keeper of the jewels (rights to the MMP). As a Corporate (LLC) entitiy, they have to have a (minimal) BoD, which I doubt really does anything.

JMHO,

SGE

Share
New Message
Please login to post a reply